Why is direct bilirubin elevated in cholestasis?

In cholestasis, conjugated bilirubin cannot be excreted into bile due to intrahepatic or extrahepatic obstruction, so it accumulates and regurgitates into the bloodstream. The direct (conjugated) fraction becomes the predominant component of total bilirubin.

Can direct bilirubin be normal if total bilirubin is high?

Yes. When direct bilirubin is normal or low and total bilirubin is elevated, the hyperbilirubinaemia is predominantly unconjugated, suggesting haemolysis, Gilbert syndrome, or a conjugation defect rather than cholestasis.

Is fasting required for a direct bilirubin test?

No. Direct bilirubin does not require fasting, though it is often drawn as part of a liver chemistry panel that may specify fasting for glucose or lipids. Prolonged fasting can raise unconjugated bilirubin but has minimal effect on the direct fraction.

Why must the specimen be protected from light?

Bilirubin is photolabile and degrades under fluorescent or ultraviolet light. Specimens left exposed will show falsely low bilirubin values, so tubes should be wrapped or kept in the dark until analysis.

What does a high direct-to-total bilirubin ratio indicate?

A ratio above approximately 20–50 per cent indicates conjugated hyperbilirubinaemia and a cholestatic pattern, prompting imaging and investigation for biliary obstruction, primary biliary cholangitis, drug-induced cholestasis, or infiltrative liver disease.

Does the result differ between laboratories?

Yes. Direct bilirubin assays vary (diazo vs enzymatic methods) and reference intervals differ by laboratory. Serial results are best compared within the same performing lab; note Quest or Access Medical Laboratories on the report.

What are Dubin–Johnson and Rotor syndromes?

These are rare inherited disorders of conjugated bilirubin excretion causing chronic, predominantly direct hyperbilirubinaemia without significant liver disease. They are diagnoses of exclusion once cholestasis and obstruction are ruled out.

BML-GAS-062gastrointestinalUSA

Bilirubin, Direct

The Direct Bilirubin test measures conjugated, water-soluble bilirubin and is the key discriminator between hepatocellular and cholestatic causes of hyperbilirubinaemia. A predominantly direct (conjugated) elevation signals impaired biliary excretion—cholestasis or biliary obstruction—while a low direct fraction points to haemolysis or conjugation defects such as Gilbert syndrome.

Biomarkers

Blood (serum)

Sample

1–2 business days

Turnaround

Fasting

What is the Direct Bilirubin test?

The Direct Bilirubin test measures the conjugated, water-soluble fraction of serum bilirubin and is ordered to distinguish conjugated from unconjugated hyperbilirubinaemia. It is the single most important piece of information for classifying jaundice: unconjugated (indirect) hyperbilirubinaemia arises from haemolysis, impaired hepatic uptake, or defective conjugation, while conjugated (direct) hyperbilirubinaemia signals cholestasis—either intrahepatic or extrahepatic—or inherited defects in biliary excretion. Practitioners order direct bilirubin when total bilirubin is elevated, when jaundice is present, or when liver chemistries suggest a cholestatic pattern (raised alkaline phosphatase and GGT). The fraction of direct to total bilirubin guides the diagnostic pathway: a predominantly indirect elevation prompts evaluation for haemolysis or Gilbert syndrome, while a predominantly direct elevation triggers imaging and investigation of bile duct obstruction, primary biliary cholangitis, drug-induced cholestasis, or infiltrative liver disease.

What does the Direct Bilirubin test measure?

DBIL(Direct (Conjugated) Bilirubin)

Range: Approximately 0–0.3 mg/dL (0–5.1 µmol/L), assay-specific.Optimal: Minimal; direct bilirubin should represent a small fraction of total bilirubin (typically <20 per cent) in the absence of cholestasis.mg/dL / µmol/L

Unconjugated bilirubin, the lipophilic product of haem catabolism, is transported to hepatocytes bound to albumin. Within the hepatocyte, UDP-glucuronosyltransferase conjugates bilirubin with glucuronic acid to form water-soluble conjugates that are excreted into bile. Direct bilirubin refers to this conjugated fraction, which reacts 'directly' in the van den Bergh diazo assay without added alcohol. It represents bilirubin that has been processed by the liver and reflects cholestatic or post-hepatic pathology when elevated out of proportion to total bilirubin.

Direct bilirubin is the key discriminator between hepatocellular and cholestatic causes of hyperbilirubinaemia. When direct bilirubin is elevated and accounts for more than approximately 20–50 per cent of total bilirubin, the pattern is conjugated hyperbilirubinaemia, which points to impaired biliary excretion—intrahepatic cholestasis, biliary obstruction, or inherited disorders of conjugated bilirubin transport. Isolated elevation of direct bilirubin without a rise in total bilirubin is unusual and may represent assay interference or Dubin–Johnson or Rotor syndromes.

Why is the Direct Bilirubin test ordered?

Investigation of jaundice, to distinguish hepatocellular, cholestatic, and pre-hepatic causes and direct further work-up
Evaluation of elevated total bilirubin found on a routine chemistry or liver function panel, to determine the conjugated fraction
Assessment of suspected biliary obstruction (choledocholithiasis, pancreatic head mass, bile duct stricture) in conjunction with alkaline phosphatase, GGT, and imaging
Work-up of cholestatic drug reactions, primary biliary cholangitis, or primary sclerosing cholangitis when liver chemistries show a cholestatic pattern
Diagnosis of inherited disorders of bilirubin excretion (Dubin–Johnson or Rotor syndromes) when conjugated hyperbilirubinaemia is chronic and other causes are excluded
Neonatal and infant jaundice evaluation, though total and direct bilirubin are usually measured together in paediatric protocols
Monitoring of known cholestatic liver disease or biliary tract disease, interpreted with trends in aminotransferases, alkaline phosphatase, and synthetic function

Sample collection and turnaround

Sample type

Blood (serum)

Fasting required

Collection method

Venipuncture at patient service centre

Turnaround

1–2 business days

Collection notes

Phlebotomy at Quest or Access Medical Laboratories draw site. Protect the specimen from light immediately after collection and during transport; bilirubin is photolabile. Separate serum promptly and analyse within a few hours or refrigerate in the dark.

Specimen requirements

Minimum 0.5 mL serum (gel separator acceptable). Protect from light at all stages. Reject grossly haemolysed or lipaemic specimens if assay interference is likely; note the performing laboratory for serial comparability.

What can affect Direct Bilirubin results?

reducesLight exposure of the specimen

Bilirubin is photolabile and degrades under fluorescent or ultraviolet light. Specimens should be protected from light and analysed promptly; prolonged exposure falsely lowers both direct and total bilirubin.

variableHaemolysis of the sample

Grossly haemolysed specimens may show spurious results and should be rejected. Mild haemolysis can interfere with the diazo reaction depending on the method.

variableLipemia and icterus

Severe lipaemia or marked hyperbilirubinaemia itself can interfere with some assay chemistries; dilution or alternative methods may be used by the laboratory.

elevatesMedications and fasting

Some drugs (rifampicin, atazanavir, indinavir) can cause isolated conjugated hyperbilirubinaemia by competing for biliary excretion. Prolonged fasting can raise unconjugated bilirubin through reduced hepatic uptake, though the direct fraction remains low.

reducesGilbert syndrome

In Gilbert syndrome, hyperbilirubinaemia is predominantly unconjugated, so the direct fraction is typically low and the direct-to-total ratio is reduced—this pattern helps exclude cholestasis.

variableSpecimen delay and storage

Delayed separation and analysis may allow some in vitro changes; direct bilirubin is reasonably stable refrigerated, but prompt analysis is preferred to avoid photodegradation.

What do Direct Bilirubin results mean?

Elevated

Conjugated hyperbilirubinaemia: extrahepatic biliary obstruction (stone, stricture, pancreatic or biliary malignancy), intrahepatic cholestasis (primary biliary cholangitis, primary sclerosing cholangitis, drug-induced cholestasis, sepsis), Dubin–Johnson or Rotor syndromes. When direct bilirubin is >50 per cent of total, the pattern is cholestatic and prompts imaging (ultrasound, MRCP) and further serological or histological investigation.

Normal

A normal direct bilirubin in the presence of elevated total bilirubin confirms unconjugated hyperbilirubinaemia. A normal direct bilirubin with normal total bilirubin excludes significant cholestasis at the time of sampling but does not rule out intermittent or resolving biliary pathology.

Reduced

Low direct bilirubin is expected when hyperbilirubinaemia is predominantly unconjugated (haemolysis, Gilbert syndrome, Crigler–Najjar syndrome). A low direct-to-total ratio effectively rules out cholestasis and redirects the work-up to pre-hepatic or hepatocellular conjugation defects.

Note: Direct bilirubin must be interpreted with total bilirubin—the fraction (direct/total) is the key discriminator. Reference intervals and assay methods differ between laboratories (diazo vs enzymatic), so serial results are best compared within the same lab. Specimen handling matters: protect from light and analyse promptly. In neonates, the threshold for pathological conjugated hyperbilirubinaemia is lower and requires urgent evaluation.

Frequently asked questions

Direct (conjugated) bilirubin has been processed by the liver and is water-soluble, excreted in bile. Indirect (unconjugated) bilirubin is the lipophilic haem breakdown product not yet conjugated. The fraction of direct to total bilirubin distinguishes cholestatic from pre-hepatic or hepatocellular causes of jaundice.

How to access the Direct Bilirubin test

The Direct Bilirubin reference page is free and open to all practitioners. Create a free practitioner account to see pricing, save tests to your list, and generate requisition forms. Verification takes 1–2 business days.

Create Free Account

About this page

Published: October 7, 2026

Last reviewed: October 7, 2026

References:

Kwo PY, et al. ACG clinical guideline: evaluation of abnormal liver chemistries. Am J Gastroenterol. (2017)
EASL clinical practice guidelines: management of cholestatic liver diseases. J Hepatol. (2009)
Roche SP, Kobos R. Jaundice in the adult patient. Am Fam Physician. (2004)
Erlinger S, Arias IM, Dhumeaux D. Inherited disorders of bilirubin transport and conjugation: new insights into molecular mechanisms and consequences. Gastroenterology. (2014)

This content is for licensed healthcare practitioners only and does not constitute medical advice. Clinical decisions should be based on the full clinical picture and not on any single test result.

Related tests

metabolic diabetes

CMP

The Comprehensive Metabolic Panel is a 14-analyte serum chemistry panel simultaneously evaluating renal function (creatinine, BUN, eGFR), hepatic function (ALT, AST, total bilirubin, albumin, total protein), metabolic status (glucose, calcium), and electrolyte-acid-base homeostasis (sodium, potassium, chloride, bicarbonate) from a single fasting serum specimen.

BML-MET-003View reference →

gastrointestinal

GGT

The GGT test measures serum gamma-glutamyl transferase, a hepatobiliary enzyme sensitive to cholestasis, alcohol, and enzyme-inducing drugs. Its principal use is confirming the hepatobiliary source of a raised alkaline phosphatase, since GGT is not present in bone. It is sensitive but non-specific and is interpreted alongside the wider liver panel.

BML-GAS-002View reference →